Suraksha Diagnostic Limited (BOM:544293)
India · Delayed Price · Currency is INR 326.15
+21.25 (6.97%)
At close: Aug 21, 2026
Suraksha Diagnostic Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 321.87 | 318.24 | 236.25 | 65.16 | 208.24 |
Depreciation & Amortization | 414.48 | 347.93 | 322 | 313.06 | 278.13 |
Other Amortization | - | 5.05 | 3.98 | 3.65 | 5.82 |
Loss (Gain) From Sale of Assets | 2.93 | 2.56 | 21.45 | 24.33 | 14.15 |
Asset Writedown & Restructuring Costs | 4.67 | 21.86 | 9.13 | - | - |
Stock-Based Compensation | 8.53 | 2.11 | - | - | - |
Provision & Write-off of Bad Debts | 0.07 | 2.68 | 4.02 | - | 0.72 |
Other Operating Activities | 85.66 | 36.43 | 44.88 | -13.53 | 107.01 |
Change in Accounts Receivable | -91.73 | -72.12 | -47.31 | 24.82 | -15.71 |
Change in Inventory | -0.83 | -13.71 | -5.16 | 0.63 | -17.81 |
Change in Accounts Payable | 74.3 | -5.19 | 3.54 | 4.81 | 16.51 |
Change in Other Net Operating Assets | -1.66 | -12.24 | 12.04 | 18.03 | -18.83 |
Operating Cash Flow | 818.29 | 633.59 | 604.81 | 440.96 | 578.23 |
Operating Cash Flow Growth | 29.15% | 4.76% | 37.16% | -23.74% | 145.93% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -673.45 | -420.24 | -454.72 | -131.67 | -192.49 |
Sale of Property, Plant & Equipment | 0.95 | 1.41 | 25.52 | 6.61 | 3.44 |
Cash Acquisitions | -32.71 | -10 | - | - | - |
Investment in Securities | 157.37 | -2.6 | 47.36 | -108.26 | -260.93 |
Other Investing Activities | 26.15 | 35.59 | 31.9 | 25.37 | 17.17 |
Investing Cash Flow | -521.7 | -395.84 | -349.95 | -207.95 | -432.81 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | 0.77 | - | 5 | 20.5 | 95.91 |
Long-Term Debt Repaid | -284.85 | -235.12 | -254.24 | -250.82 | -223.74 |
Net Debt Issued (Repaid) | -284.07 | -235.12 | -249.24 | -230.32 | -127.83 |
Other Financing Activities | -2.85 | -5.37 | -2.05 | -12.96 | -15.02 |
Financing Cash Flow | -286.92 | -240.48 | -251.29 | -243.28 | -142.85 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Cash Flow | 9.67 | -2.73 | 3.57 | -10.27 | 2.57 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 144.85 | 213.35 | 150.09 | 309.29 | 385.74 |
Free Cash Flow Growth | -32.11% | 42.15% | -51.47% | -19.82% | 375.57% |
Free Cash Flow Margin | 4.67% | 8.46% | 6.86% | 16.27% | 17.28% |
Free Cash Flow Per Share | 2.78 | 4.10 | 2.82 | 5.80 | 7.24 |
Levered Free Cash Flow | 76.08 | 123.69 | 46.55 | 270.18 | 287.95 |
Unlevered Free Cash Flow | 154.54 | 176.09 | 101.48 | 326.8 | 343.23 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 2.85 | 6.37 | 9.08 | 12.96 | 15.02 |
Cash Income Tax Paid | 133.58 | 105.82 | 86.1 | 71.93 | 27.96 |
Change in Working Capital | -19.91 | -103.26 | -36.9 | 48.29 | -35.84 |